Morgan Stanley Knock-Out BMRN/ DE000MG8DZD5 /
05/08/2024 20:59:52 | Chg.-0.34 | Bid21:57:08 | Ask21:57:08 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.90EUR | -15.18% | 1.85 Bid Size: 1,500 |
1.87 Ask Size: 1,500 |
BioMarin Pharmaceuti... | 60.0821 USD | 31/12/2078 | Call |
GlobeNewswire
30/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharm...
GlobeNewswire
28/06
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...
GlobeNewswire
13/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...
GlobeNewswire
05/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...
GlobeNewswire
02/10/2023
California’s top scientific innovators selected as finalists for the 20th annual California Life Sci...
GlobeNewswire
01/03/2022
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...
Newsfile Corp
04/02/2022
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.
GlobeNewswire
24/01/2022
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.
GlobeNewswire
23/12/2021
Lifshitz Law Firm, P.C. Announces Investigations of Amarin Corporation plc (NASDAQGM: AMRN), BioMari...
GlobeNewswire
21/12/2021
BMRN FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioMarin Pharmaceutical Inc....
GlobeNewswire
20/12/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...
GlobeNewswire
17/12/2021
ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure C...
GlobeNewswire
07/12/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...
GlobeNewswire
07/12/2021
ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Befor...
GlobeNewswire
01/12/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...
GlobeNewswire
30/11/2021
AMRN, BMRN & RECAF – Upcoming Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC
GlobeNewswire
28/11/2021
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losse...
GlobeNewswire
19/11/2021
AMRN, BMRN & RECAF – Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC
GlobeNewswire
15/11/2021
Autolus Therapeutics announces the appointment of Dr. William D. Young as a Non-Executive Director